Politics and drugs
Medical marijuana and biosimilars are two topics where 'the will of the people' push decisions
A conversation with W. Scott Evangelista, Quintiles
Manufacturers: Get ready for global trade account management
Partnering to diversify yields rapid growth
A family-owned pharmaceutical manufacturer plots a 21st-century growth plan
Campbell Alliance updates, expands its commercial launch consulting services
More executional capabilities derive from affiliation with parent, inVentiv Health
HealthPrize touts its success with 'gamification' in adherence programs
Company uses online media to promote fill rates by more than 50%
Exostar grows its network of collaborative tools in life sciences
Identity Hub expedites access to regulated content in prescribing and other commercial applications
Symphony Health Solutions builds a 5-million-patient, longitudinal cardiovascular registry
Collaboration with American College of Cardiology could result in new health-outcomes results
Rite Aid to buy EnvisionRx, continuing a reshaping of US drug distribution
$2-billion acquisition brings a $5-billion/yr PBM to Rite Aid's 4,600 retail stores
Independent physicians and their clinics remain a dominant channel for specialty distribution, says HDMA
Association's annual specialty-distribution study focuses trend in oncology, chronic diseases
Preventing and Managing Drug Shortages--PDA Technical Report 68
The Parenteral Drug Association offers risk management guidance*
'Capacity crunch' is the theme of HPCLC meeting
2015 spring meeting focuses on meeting transportation bottlenecks
Alliance Life Sciences partners with Revitas to better manage pharma revenue practices
1.5-10% improvement in 'revenue capture' is possible
Next agg-spend deadline looms with little buzz from industry
Reporting by pharma companies on spending on physicians is becoming a non-event
The biosimilars payoff in the US might be small and fleeting
Analysis from Prime Therapeutics points to severe cost hurdles for biosimilars developed and marketed in the US
Bayer upgrades temperature-controlled packaging and saves money while doing so
New design from Emball'Iso triples payload capacity
Medical marijuana looks for a place in conventional drug distribution
It's still early days in making medical marijuana--and cannabis-based pharmaceuticals--part of normal dispensing
Cloud-based services manage regulated content better
Unifying the management of clinical research documentation and marketing content saves time and accelerates speed-to-therapy
2015 Hub Services Report
Comprehensive patient care becomes the unifying theme of pharma hubs
Advances in cold chain packaging
GDP standards drive higher performance standards for packaging
ACOs raise the stakes for evidence-based medicine
Manufacturers will need to refine their interactions with healthcare providers and produce better outcomes research and adherence programs to compete
Pharmaceutical cold chain logistics is a $10-billion global industry
Pharmaceutical Commerce's annual Cold Chain Sourcebook projects 44% growth over the 2013-2019 span
